Displaying drugs 2651 - 2675 of 9152 in total
FB-101
FB-101 is a c-Abl inhibitor. Developed by 1st Biotherapeutics, it is being investigated for the treatment of neurological disorders, such as Parkinson's Disease and amyotrophic lateral sclerosis (ALS).
Experimental
Investigational
Matched Synonyms: … FB 101 …
Matched Name: … FB-101 …
Matched Description: … FB-101 is a c-Abl inhibitor. …
Matched Name: … FB-101 …
Matched Description: … FB-101 is a c-Abl inhibitor. …
ACT-101
ACT-101 is a recombinant human alpha-fetoprotein or rhAFP.
Investigational
Matched Synonyms: … ACT 101 …
Matched Name: … ACT-101 …
Matched Description: … ACT-101 is a recombinant human alpha-fetoprotein or rhAFP. …
Matched Name: … ACT-101 …
Matched Description: … ACT-101 is a recombinant human alpha-fetoprotein or rhAFP. …
EGT-101
EGT-101 is an adeno-associated viral vector serotype 9 (AAV9) vector-based gene therapy consisting of the human sulfamidase (SGSH) transgene. Developed by Esteve Pharmaceuticals, it is being investigated for Sanfilippo syndrome type A.
Investigational
Matched Synonyms: … EGT 101 …
Matched Name: … EGT-101 …
Matched Description: … EGT-101 is an adeno-associated viral vector serotype 9 (AAV9) vector-based gene therapy consisting of …
Matched Name: … EGT-101 …
Matched Description: … EGT-101 is an adeno-associated viral vector serotype 9 (AAV9) vector-based gene therapy consisting of …
TTI-101
Investigational
Matched Synonyms: … Stat3 inhibitor tti-101 ... Benzenesulfonamide, n-(1',2-dihydroxy(1,2'-binaphthalen)-4'-yl)-4-methoxy- …
Matched Name: … TTI-101 …
Matched Iupac: … N-{1',2-dihydroxy-[1,2'-binaphthalen]-4'-yl}-4-methoxybenzene-1-sulfonamide …
Matched Name: … TTI-101 …
Matched Iupac: … N-{1',2-dihydroxy-[1,2'-binaphthalen]-4'-yl}-4-methoxybenzene-1-sulfonamide …
DYN-101
DYN-101 is an antisense product candidate designed to reduce the expression of dynamin 2 protein.
Investigational
Matched Synonyms: … DYN 101 …
Matched Name: … DYN-101 …
Matched Description: … DYN-101 is an antisense product candidate designed to reduce the expression of dynamin 2 protein. …
Matched Name: … DYN-101 …
Matched Description: … DYN-101 is an antisense product candidate designed to reduce the expression of dynamin 2 protein. …
AMY-101
AMY-101, also known as compstatin 40, is a peptidic inhibitor of the central complement component C3. AMY-101 is under investigation in clinical trial NCT03694444 (A Study of the C3 Complement Inhibitor AMY-101 in Adults With Gingivitis).
Investigational
Matched Synonyms: … AMY 101 …
Matched Name: … AMY-101 …
Matched Iupac: … ]-3-methylpentanamido]-7-(3-carbamimidamidopropyl)-4-{[(1S,2S)-1-carbamoyl-2-methylbutyl](methyl)carbamoyl ... 2-[(4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-34-[(2S,3S)-2-[(2R)-2-amino-3-(4-hydroxyphenyl)propanamido …
Matched Description: … AMY-101 in Adults With Gingivitis). ... AMY-101, also known as compstatin 40, is a peptidic inhibitor of the central complement component C3. ... AMY-101 is under investigation in clinical trial NCT03694444 (A Study of the C3 Complement Inhibitor …
Matched Name: … AMY-101 …
Matched Iupac: … ]-3-methylpentanamido]-7-(3-carbamimidamidopropyl)-4-{[(1S,2S)-1-carbamoyl-2-methylbutyl](methyl)carbamoyl ... 2-[(4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-34-[(2S,3S)-2-[(2R)-2-amino-3-(4-hydroxyphenyl)propanamido …
Matched Description: … AMY-101 in Adults With Gingivitis). ... AMY-101, also known as compstatin 40, is a peptidic inhibitor of the central complement component C3. ... AMY-101 is under investigation in clinical trial NCT03694444 (A Study of the C3 Complement Inhibitor …
AMP-101
AMP-101 is a gene therapy comprising an adeno-associated virus type 9 (AAV9) vector encoding the human Dok-7 protein. It is under investigation for the treatment of Dok-7-associated myasthenia.
Investigational
Matched Name: … AMP-101 …
Matched Description: … Dok-7 protein. ... AMP-101 is a gene therapy comprising an adeno-associated virus type 9 (AAV9) vector encoding the human ... It is under investigation for the treatment of Dok-7-associated myasthenia. …
Matched Description: … Dok-7 protein. ... AMP-101 is a gene therapy comprising an adeno-associated virus type 9 (AAV9) vector encoding the human ... It is under investigation for the treatment of Dok-7-associated myasthenia. …
7-cyano-7-deazaguanine
Experimental
Matched Synonyms: … 7-CN-7-deazaG ... 7-Cyano-7-carbaguanine …
Matched Name: … 7-cyano-7-deazaguanine …
Matched Iupac: … 4-hydroxy-2-imino-1H,2H,7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile …
Matched Name: … 7-cyano-7-deazaguanine …
Matched Iupac: … 4-hydroxy-2-imino-1H,2H,7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile …
LAX-101
LAX-101 treats hungtington’s disease, not just the symptoms but the disease itself. The active molecule in LAX-101 is Eicosapentaenoic Acid (EPA). All molecules of EPA are identical. The molecules of EPA found in LAX-101 are identical to the molecules of EPA found in fish oil food supplements.
Investigational
Matched Name: … LAX-101 …
Matched Description: … LAX-101 treats hungtington’s disease, not just the symptoms but the disease itself. ... The active molecule in LAX-101 is Eicosapentaenoic Acid (EPA). All molecules of EPA are identical. ... The molecules of EPA found in LAX-101 are identical to the molecules of EPA found in fish oil food supplements …
Matched Description: … LAX-101 treats hungtington’s disease, not just the symptoms but the disease itself. ... The active molecule in LAX-101 is Eicosapentaenoic Acid (EPA). All molecules of EPA are identical. ... The molecules of EPA found in LAX-101 are identical to the molecules of EPA found in fish oil food supplements …
AP-101
AP-101 is a recombinant human antibody directed against human misfolded superoxide dismutase 1.
Investigational
Matched Name: … AP-101 …
Matched Description: … AP-101 is a recombinant human antibody directed against human misfolded superoxide dismutase 1. …
Matched Description: … AP-101 is a recombinant human antibody directed against human misfolded superoxide dismutase 1. …
YA-101
Investigational
Matched Synonyms: … 1h-benzimidazol-6-ol, 2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)- ... 2-[[(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazol-5-ol …
Matched Name: … YA-101 …
Matched Name: … YA-101 …
AVB-101
AVB-101 is a recombinant AAV9 vector encoding the human progranulin (PGRN) gene.
Investigational
Matched Name: … AVB-101 …
Matched Description: … AVB-101 is a recombinant AAV9 vector encoding the human progranulin (PGRN) gene. …
Matched Description: … AVB-101 is a recombinant AAV9 vector encoding the human progranulin (PGRN) gene. …
EVT-101
Investigational
Matched Name: … EVT-101 …
Matched Iupac: … 5-[3-(difluoromethyl)-4-fluorophenyl]-3-[(2-methyl-1H-imidazol-1-yl)methyl]pyridazine dihydrochloride …
Matched Iupac: … 5-[3-(difluoromethyl)-4-fluorophenyl]-3-[(2-methyl-1H-imidazol-1-yl)methyl]pyridazine dihydrochloride …
CUDC-101
CUDC-101 has been used in trials studying the treatment of Cancer, Tumors, Liver Cancer, Breast Cancer, and Gastric Cancer, among others.
Investigational
Matched Name: … CUDC-101 …
Matched Iupac: … 7-({4-[(3-ethynylphenyl)amino]-7-methoxyquinazolin-6-yl}oxy)-N-hydroxyheptanamide …
Matched Description: … CUDC-101 has been used in trials studying the treatment of Cancer, Tumors, Liver Cancer, Breast Cancer …
Matched Iupac: … 7-({4-[(3-ethynylphenyl)amino]-7-methoxyquinazolin-6-yl}oxy)-N-hydroxyheptanamide …
Matched Description: … CUDC-101 has been used in trials studying the treatment of Cancer, Tumors, Liver Cancer, Breast Cancer …
ATSN-101
ATSN-101 is a adeno-associated virus serotype 5 encoding human retinal guanylate cyclase 1 gene (AAV5-GUCY2D)
Investigational
Matched Name: … ATSN-101 …
Matched Description: … ATSN-101 is a adeno-associated virus serotype 5 encoding human retinal guanylate cyclase 1 gene (AAV5 …
Matched Description: … ATSN-101 is a adeno-associated virus serotype 5 encoding human retinal guanylate cyclase 1 gene (AAV5 …
CYNK-101
CYNK-101 is an allogeneic human placental hematopoietic stem cell-derived natural killer (NK) cell therapy product that is genetically modified to express a variant of CD16 (CD16VP).
Investigational
Matched Name: … CYNK-101 …
Matched Description: … CYNK-101 is an allogeneic human placental hematopoietic stem cell-derived natural killer (NK) cell therapy …
Matched Description: … CYNK-101 is an allogeneic human placental hematopoietic stem cell-derived natural killer (NK) cell therapy …
ST-101
ST-101 is a small peptide antagonist of C/EBPβ and T-type calcium channel activator. ST101 has been used in trials studying the treatment of Essential Tremor and Alzheimer's Disease.
Investigational
Matched Synonyms: … ST-101 (D-AMINO ACID PEPTIDE) …
Matched Name: … ST-101 …
Matched Description: … ST-101 is a small peptide antagonist of C/EBPβ and T-type calcium channel activator. …
Matched Name: … ST-101 …
Matched Description: … ST-101 is a small peptide antagonist of C/EBPβ and T-type calcium channel activator. …
SUN-101
Investigational
Matched Synonyms: … (2R)-4-(ethylamino)-1-[4-[[(2R)-4-(ethylamino)-2-hydroxybutyl]amino]butylamino]butan-2-ol …
Matched Name: … SUN-101 …
Matched Name: … SUN-101 …
Biomed 101
Biomed 101 is investigated for use/treatment in adverse effects (chemotherapy) and renal cell carcinoma. Biomed 101 is a solid. Biomed 101 binds to the leukotriene B4 receptor, but does not affect interleukin-2 antitumor activity.
Investigational
Matched Name: … Biomed 101 …
Matched Description: … Biomed 101 is a solid. ... Biomed 101 is investigated for use/treatment in adverse effects (chemotherapy) and renal cell carcinoma ... Biomed 101 binds to the leukotriene B4 receptor, but does not affect interleukin-2 antitumor activity …
Matched Description: … Biomed 101 is a solid. ... Biomed 101 is investigated for use/treatment in adverse effects (chemotherapy) and renal cell carcinoma ... Biomed 101 binds to the leukotriene B4 receptor, but does not affect interleukin-2 antitumor activity …
AV-101
AV-101 has been used in trials studying the treatment of Neuropathic Pain.
Investigational
Matched Synonyms: … (2S)-2-amino-4-(2-amino-4-chlorophenyl)-4-oxobutanoic acid ... L-4-CL-KYN ... 4-chlorokynurenine …
Matched Name: … AV-101 …
Matched Iupac: … (2S)-2-amino-4-(2-amino-4-chlorophenyl)-4-oxobutanoic acid …
Matched Description: … AV-101 has been used in trials studying the treatment of Neuropathic Pain. …
Matched Name: … AV-101 …
Matched Iupac: … (2S)-2-amino-4-(2-amino-4-chlorophenyl)-4-oxobutanoic acid …
Matched Description: … AV-101 has been used in trials studying the treatment of Neuropathic Pain. …
INBRX-101
INBRX-101 is a recombinant human alpha-1 antitrypsin (AAT)-Fc fusion protein.
Investigational
Matched Name: … INBRX-101 …
Matched Description: … INBRX-101 is a recombinant human alpha-1 antitrypsin (AAT)-Fc fusion protein. …
Matched Description: … INBRX-101 is a recombinant human alpha-1 antitrypsin (AAT)-Fc fusion protein. …
GI-101
GI-101 is a bi-specific fragment crystallizable region (Fc) fusion protein containing a cluster of differentiation 80 ectodomain as an N-terminal moiety and interleukin-2 variant as a C-terminal moiety conjugated with human immunoglobulin G4 Fc.
Investigational
Matched Name: … GI-101 …
Matched Description: … GI-101 is a bi-specific fragment crystallizable region (Fc) fusion protein containing a cluster of differentiation …
Matched Description: … GI-101 is a bi-specific fragment crystallizable region (Fc) fusion protein containing a cluster of differentiation …
Displaying drugs 2651 - 2675 of 9152 in total